Pietro Andrea A.
- Country
- Italy
- Department
- A.O. “Ospedali Riuniti Villa Sofia-Cervello”
Research Overview
Data & Insights
Has run more than one trial at 0 of 30 partner sites.
Specializations
Myeloid Neoplasms
Focuses on Acute Myeloid Leukemia including FLT3‑mutated and NPM1‑mutated subtypes, as well as therapy‑related myeloid disorders and stem‑cell transplantation strategies.
- Acute Myeloid Leukemia with FLT3 mutation
- NPM1‑mutated AML
- Allogeneic hematopoietic stem cell transplant in AML
- Molecular relapse monitoring in AML
Therapeutic development emphasizes targeted inhibitors and post‑remission consolidation.
Lymphoid Malignancies
Investigates a spectrum of Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, and diverse lymphoma entities such as Diffuse Large B‑Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma.
- Philadelphia chromosome‑positive ALL
- B‑cell precursor ALL
- Chronic Lymphocytic Leukemia (CLL)
- Mantle Cell Lymphoma
- Follicular Lymphoma
- Diffuse Large B‑Cell Lymphoma
- Marginal Zone Lymphoma
Research integrates novel BTK inhibitors, BCL‑2 antagonists, and immunotherapy combinations.
Myeloproliferative Disorders and Graft‑Versus‑Host Disease
Covers Primary Myelofibrosis, Post‑Polycythaemia Vera Myelofibrosis, Post‑Essential Thrombocythemia Myelofibrosis, and chronic graft‑versus‑host disease management.
- Primary Myelofibrosis
- Post‑Polycythaemia Vera Myelofibrosis
- Post‑Essential Thrombocythemia Myelofibrosis
- Chronic Graft‑Versus‑Host Disease
- Transplant‑associated Thrombotic Microangiopathy
Efforts target JAK‑STAT pathway modulation and immune‑regulatory strategies.
Inflammatory Bowel Disease and Gastrointestinal Immunology
Addresses chronic intestinal inflammation, including Crohn’s Disease and Ulcerative Colitis, as well as related conditions such as Eosinophilic Gastritis.
- Crohn’s Disease
- Ulcerative Colitis
- Moderately to severely active UC
- Eosinophilic Gastritis
- Moderate to severe IBD
Therapeutic focus includes cytokine blockade and gut‑targeted biologics.
Hereditary Angioedema and Vascular Disorders
Specializes in Hereditary Angioedema (type I/II) and acute complement‑mediated attacks, alongside cerebrovascular prevention strategies for patients after ischemic stroke.
- Hereditary Angioedema type I
- Hereditary Angioedema type II
- Acute HAE attacks
- Ischemic stroke secondary prevention
- Transient ischemic attack risk reduction
Research evaluates on‑demand kallikrein inhibitors and antithrombotic agents.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.